Anti-EGFR strategies as an incremental step for the treatment of colorectal cancer patients: moving from scientific evidence to clinical practice

By Scartozzi Mario   Pierantoni Chiara   Berardi Rossana   Squadroni Michela   Cascinu Stefano  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 281-287

Informa Healthcare

Access to resources Recommend Favorite

Beyond RAS: The Role of Epidermal Growth Factor Receptor (EGFR) and its Network in the Prediction of Clinical Outcome During Anti-EGFR Treatment in Colorectal Cancer Patients

By  

Current Drug Targets, Vol. 15, Iss. 13, 2014-12 ,pp. : 1225-1230

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-EGFR Strategy for Colorectal Cancer: Searching for the Real Target

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 8, 2006-10 ,pp. : 541-543

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Egfr Therapy in Colorectal Cancer: How to Choose The Right Patient

By  

Current Drug Targets, Vol. 10, Iss. 10, 2009-10 ,pp. : 1033-1040

Bentham Science Publishers

Access to resources Recommend Favorite

Patient-Tailored Treatments with Anti-EGFR Monoclonal Antibodies in Advanced Colorectal Cancer: KRAS and Beyond

By  

Current Cancer Drug Targets, Vol. 12, Iss. 4, 2012-04 ,pp. : 316-328

Bentham Science Publishers

Access to resources Recommend Favorite